Article Information
History
- March 31, 2020.
Article Versions
- Version 1 (March 27, 2020 - 05:12).
- Version 2 (March 30, 2020 - 17:42).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Marjolein F.Q. Kluytmans-van den Bergh, PhD1,2,3,*,
- Anton G.M. Buiting, PhD4,5,
- Suzan D. Pas, PhD6,
- Robbert G. Bentvelsen, MD7,8,
- Wouter van den Bijllaardt, MD7,
- Anne J.G. van Oudheusden, MSc5,
- Miranda M.L. van Rijen, PhD1,
- Jaco J. Verweij, PhD4,
- Marion P.G. Koopmans, PhD9 and
- Jan A.J.W. Kluytmans, PhD1,3,6
- 1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
- 2Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
- 3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
- 4Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
- 5Department of Infection Control, Elisabeth-TweeSteden Hospital, the Netherlands
- 6Microvida Laboratory for Microbiology, Bravis Hospital, Roosendaal, the Netherlands
- 7Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands
- 8Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
- 9Department of Virology, Erasmus Medical Center, Rotterdam, the Netherlands
- ↵*Corresponding author
Marjolein F.Q. Kluytmans-van den Bergh, Department of Infection Control, Amphia Hospital, PO Box 90158, 4800 RK Breda, the Netherlands, T: +31-6-51215336, E: marjoleinkluytmans{at}gmail.com